glp-1 weight loss drug market news today new Harvard-led study suggests women taking weight-loss medications like Ozempic and Wegovy may have an advantage in the job market.⁠ ⁠ Researchers found that unemployed women using GLP-1 medications were 27% Investing in GLP-1 Drugs: Eli

Chinas growing diabetic patient base and increased government initiatives for diabetes care contribute to market growth

According to Eurostat, the proportion of people aged 65 and older in the EU is predicted to increase from 20% in 2020 to approximately 30% by 2050

Institutional Review Board Statement This study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board at Charleston Area Medical Center in Charleston, West Virginia

So why arent more people able to get insurance coverage for GLP-1 medications

This may be attributed to the stronger impact of GLP-1RAs on ventricular structure and function in this population [45]

Strong clinical evidence demonstrating sustained weight loss and cardiometabolic benefits is boosting confidence among patients and healthcare providers